Procaps Group, S.A Income After Taxes 2020-2023 | PROCF

Procaps Group, S.A income after taxes from 2020 to 2023. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Procaps Group, S.A Annual Income After Taxes
(Millions of US $)
2022 $43
2021 $-101
2020 $-10
2020 $-13
2019 $-17
2019 $-0
2018 $-0
Procaps Group, S.A Quarterly Income After Taxes
(Millions of US $)
2023-09-30 $8
2023-06-30 $27
2023-03-31 $7
2022-12-31 $10
2022-09-30 $23
2022-06-30 $-7
2022-03-31 $16
2021-12-31 $28
2021-09-30 $-111
2021-06-30 $-1
2021-03-31 $-17
2020-12-31 $-6
2020-09-30 $-1
2020-06-30 $-4
2020-03-31 $2
2019-12-31
2019-09-30
2019-06-30
2019-03-31 $-0
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49